As global markets experience a rebound, with major U.S. stock indexes climbing higher due to cooling inflation and robust bank earnings, the spotlight is on small-cap stocks that could benefit from ...

SEOUL, Jan. 15 (Yonhap) -- SK Biopharmaceuticals Co. (SK Biopharm), a biopharmaceutical arm of SK Group, will establish a joint venture with a major South American biopharma, Eurofarma, in the United ...

Korea’s top biopharmaceutical firms, Celltrion and Samsung Biologics, envisioned their future strategies for expansion at J.P.Morgan Healthcare Conference (JPM) 2025 in San Francisco, Wednesday.

SAN FRANCISCO -- SK Biopharmaceuticals plans to establish a joint venture with Eurofarma, one of Latin America’s leading pharmaceutical companies, to commercialize a new AI-based epilepsy ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

1 Day 326030 0.09% DJIA 0.34% S&P 500 -0.40% Health Care/Life Sciences 0.43% ...

We've identified the following companies as similar to Sk Biopharmaceuticals Co Ltd because they operate in a related industry or sector. We also considered size, growth, and various financial metrics ...

Overview: UPM-Kymmene Oyj, along with its subsidiaries, operates in the forest-based bioindustry across Europe, North America, Asia, and internationally with a market cap of €14.17 billion. Operations ...